DCGI

DCGI gives limited approval to market Stempeutics’ allogeneic cell therapy

Read more

DCG(I) bans 344 drugs constituting fixed dose combinations, but will it hold?

Read more

Indian scientists develop breakthrough dengue drug

Read more

Hetero receives DCG(I) approval for fixed-dose combination therapy ‘Ledipasvir-Sofosbuvir’

Read more

EU’s ban of 700 pharma products will impact Indian pharma export by $1 bn

Read more

New drug capsule shells offer new choice: veg or non-veg

Read more